Premium
TREATMENT WITH TRICHOSTATIN A RESTORES SENSITIVITY TO GEFITINIB AND IMPAIRS CANCER STEM CELLS FEATURES IN EGFR‐MUTANT NON‐SMALL CELL LUNG CANCER CELLS
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13419_156
Subject(s) - medicine , gefitinib , lung cancer , cancer research , mutant , trichostatin a , cancer stem cell , cancer , cancer cell , oncology , epidermal growth factor receptor , histone deacetylase , histone , genetics , biology , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom